A new nomogram model incorporates risk factors for postoperative recurrence in patients with ECRSwNP to identify patients at high risk for ECRSwNP recurrence.
Emerging research shows mast cells play a role in the etiology of chronic rhinosinusitis with nasal polyps and may be a new treatment target for the condition.